Cargando…
A Metabolic Pattern in Healthy Subjects Given a Single Dose of Metformin: A Metabolomics Approach
Metformin is a widely prescribed medication for the treatment of type 2 diabetes mellitus (T2DM). It possesses effective roles in various disorders, including cancer, dyslipidemia, and obesity. However, the underlying mechanisms of metformin's multiple benefits are not fully understood. Herein,...
Autores principales: | Dahabiyeh, Lina A., Mujammami, Muhammad, Arafat, Tawfiq, Benabdelkamel, Hicham, Alfadda, Assim A., Abdel Rahman, Anas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319764/ https://www.ncbi.nlm.nih.gov/pubmed/34335266 http://dx.doi.org/10.3389/fphar.2021.705932 |
Ejemplares similares
-
Lipids Alterations Associated with Metformin in Healthy Subjects: An Investigation Using Mass Spectrometry Shotgun Approach
por: Dahabiyeh, Lina A., et al.
Publicado: (2022) -
Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated With Metformin
por: Aleidi, Shereen M., et al.
Publicado: (2021) -
The metabolomics approach revealed a distinctive metabolomics pattern associated with hyperthyroidism treatment
por: Jaber, Malak A., et al.
Publicado: (2022) -
Metabolomic profile of patients on levothyroxine treatment for hypothyroidism
por: Benabdelkamel, Hicham, et al.
Publicado: (2023) -
Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin
por: Alshahrani, Awad, et al.
Publicado: (2023)